rs994170964
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000441.2(SLC26A4):c.2170G>A(p.Asp724Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000435 in 1,609,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D724G) has been classified as Pathogenic.
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A4 | ENST00000644269.2 | c.2170G>A | p.Asp724Asn | missense_variant | 19/21 | NM_000441.2 | ENSP00000494017.1 | |||
SLC26A4 | ENST00000644846.1 | n.*72G>A | non_coding_transcript_exon_variant | 8/10 | ENSP00000494344.1 | |||||
SLC26A4 | ENST00000644846.1 | n.*72G>A | 3_prime_UTR_variant | 8/10 | ENSP00000494344.1 | |||||
SLC26A4 | ENST00000492030.2 | n.377-21G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152222Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1456890Hom.: 0 Cov.: 28 AF XY: 0.00000276 AC XY: 2AN XY: 725160
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 724 of the SLC26A4 protein (p.Asp724Asn). This variant is present in population databases (no rsID available, gnomAD 0.03%). This missense change has been observed in individual(s) with Pendred syndrome (PMID: 15355436). ClinVar contains an entry for this variant (Variation ID: 553188). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC26A4 protein function with a positive predictive value of 95%. This variant disrupts the p.Asp724 amino acid residue in SLC26A4. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14679580, 15811013, 19017801, 24224479). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:1
Pathogenic, no assertion criteria provided | research | Wonkam Laboratory, Johns Hopkins University | Jan 06, 2024 | The variant NM_000441.2 c.2170G>A is predicted by multiple lines of computational evidence supporting a deleterious effect on the gene or gene product (PP3), Located in a mutational hot spot and/or critical and well-established functional domain (PM1), Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before (PM5), Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2), Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (PP1), Patient's phenotype or family history is highly specific for a disease with a single genetic etiology (PP4). This variant was found as compound heterozygote with a known established pathogenic variant NM_000441.2 c.471C>T - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 17, 2023 | Variant summary: SLC26A4 c.2170G>A (p.Asp724Asn) results in a conservative amino acid change located in the STAS domain (IPR002645) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 150994 control chromosomes (gnomAD). c.2170G>A has been reported in the literature as a biallelic genotype in at least one individual affected with Pendred Syndrome (Blons_2004). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. However, a different missense variant occuring at the same codon has been previously classified as pathogenic/likely pathogenic (p.Asp724Gly, ClinVar: 228396), suggesting this residue may be of clinical significance. The following publication has been ascertained in the context of this evaluation (PMID: 15355436). One ClinVar submitter has assessed the variant since 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Pendred syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Aug 04, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at